C-Type Lectin Domain Family 9, Member A (CLEC9A) ELISA Kits

CLEC9A is a group V C-type lectin-like receptor (CTLR) that functions as an activation receptor and is expressed on myeloid lineage cells (Huysamen et al., 2008 [PubMed 18408006]).[supplied by OMIM, Aug 2008].. Zusätzlich bieten wir Ihnen CLEC9A Antikörper (99) und CLEC9A Proteine (7) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
CLEC9A 232414 Q8BRU4
CLEC9A 283420 Q6UXN8
Anti-Ratte CLEC9A CLEC9A 502901 D4AD02
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top CLEC9A ELISA Kits auf antikoerper-online.de

Showing 2 out of 5 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Anbieter Lieferzeit Preis Details
Human 0.078 ng/mL 0.312-20 ng/mL Typical standard curve 96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$910.56
Details
Maus
  96 Tests Anmelden zum Anzeigen 21 bis 31 Tage
$796.95
Details

Weitere ELISA Kits für CLEC9A Interaktionspartner

Mouse (Murine) C-Type Lectin Domain Family 9, Member A (CLEC9A) Interaktionspartner

  1. DNGR-1 deficiency leads to exacerbated caerulein-induced necrotizing pancreatitis and increased pathology during systemic Candida albicans infection without affecting fungal burden.

  2. Clec9A and Clec12A exhibit different intrinsic capacities to elicit MHC I and MHC II presentation following direct antigen targeting

  3. DNGR-1 also regulated Trm cell generation.

  4. A specific deletion of DNGR-1 limits the development of atherosclerosis and vascular inflammation.

  5. The authors describe a conformational change that occurs in the neck region of DNGR-1 in a pH- and ionic strength-dependent manner and that controls cross-presentation of dead cell-associated antigens.

  6. Study found presence of DNGR-1 in the brain, providing a potential marker for the study of a specific denditritic brain cell subset

  7. A dependence on DNGR-1 for RSV-specific CD8(+) T-cell responses was observed.

  8. Genetic tracing of DNGR-1 expression history specifically marks cells traditionally ascribed to the dendritic cells lineage, and this restriction is maintained after inflammation.

  9. Clec9A-positive dendritic cells control susceptibility of mice to experimental cerebral malaria.

  10. High expression of DNGR-1 specifically and universally identifies a unique dendritic cells subset in mouse and humans.

  11. Loss of DNGR-1 impaired the CD8 positive lymphocyte cytotoxic response to vaccinia virus, especially against those virus strains that are most dependent on cross-presentation.

  12. DNGR-1 regulated cross-priming in non-infectious settings such as immunization with antigen-bearing dead cells, as well as in highly immunogenic situations such as infection with herpes simplex virus type 1.

  13. propose that Clec9A provides targeted recruitment of the adaptive immune system during infection and can also be utilized to enhance immune responses generated by vaccines.

  14. Data show that targeting of antigen to Clec9A in batf3 null mice produced enhanced antibody responses.

  15. For production of cytotoxic T cells, DEC-205 and Clec9A, but not Clec12A, are effective targets for antibody-mediated delivery of antigens for vaccination, although only in the presence of adjuvants.

  16. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.

  17. CLEC9A functions as an activation receptor

  18. DC, NK lectin group receptor-1 (DNGR-1) is a C-type lectin of the NK cell receptor group

  19. analysis of differences between mouse and human Clec9A

  20. CLEC9A functions as a SYK-coupled C-type lectin receptor to mediate sensing of necrosis by the principal dendritic-cell subset involved in regulating cross-priming to cell-associated antigens

Human C-Type Lectin Domain Family 9, Member A (CLEC9A) Interaktionspartner

  1. Clec9a is responsible for the antigen cross-presentation of dendritic cell subsets and may be a target of immunotherapy

  2. findings demonstrate that CLEC9A is a specialized receptor that modulates the innate immune response when there is a mycobacterial infection

  3. Data indicate that blood dendritic cell antigen 3 BDCA3(+) and C-type lectin domain family 9, member A CLEC9A(+) dendritic cells (DC) are of major importance in the induction of anti-viral and anti-tumor immunity.

  4. Activated dendritic cell subsets expressing CD141/CLEA9A/CD1c, likely recruited into the tubulointerstitium, are positioned to play a role in the development of fibrosis and, thus, progression to chronic kidney disease.

  5. study showsn that the DNGR-1 ligand is preserved from yeast to man and corresponds to the F-actin component of the cellular cytoskeleton; identification of F-actin as a DNGR-1 ligand suggests that cytoskeletal exposure is a universal sign of cell damage that can be targeted by the innate immune system to initiate immunity

  6. High expression of DNGR-1 specifically and universally identifies a unique dendritic cells subset in mouse and humans.

  7. propose that Clec9A provides targeted recruitment of the adaptive immune system during infection and can also be utilized to enhance immune responses generated by vaccines.

  8. Data show that CLEC9A is only expressed on immature BDCA3(+) myeloid dendritic cells (mDCs).

  9. For production of cytotoxic T cells, transgenic DEC-205 and Clec9A, but not Clec12A, are effective targets for antibody-mediated delivery of antigens for vaccination, although only in the presence of adjuvants.

  10. A population of human dendritic cells (DC) that expresses DNGR-1 (CLEC9A) and high levels of BDCA3 and resembles mouse CD8alpha+ DCs in phenotype and function, is characterized.

  11. The paper cited (J Clin Invest. 2008 Jun;118(6):2098-110) is the first characterization of human and mouse CLEC9A (a.k.a DNGR-1)

  12. CLEC9A functions as an activation receptor

  13. analysis of differences between mouse and human Clec9A

  14. CLEC9A functions as a SYK-coupled C-type lectin receptor to mediate sensing of necrosis by the principal dendritic-cell subset involved in regulating cross-priming to cell-associated antigens

CLEC9A Antigen-Profil

Beschreibung des Gens

CLEC9A is a group V C-type lectin-like receptor (CTLR) that functions as an activation receptor and is expressed on myeloid lineage cells (Huysamen et al., 2008

Genbezeichner und Symbole assoziert mit CLEC9A

  • C-type lectin domain family 9, member a (Clec9a) Antikörper
  • C-type lectin domain containing 9A (CLEC9A) Antikörper
  • C-type lectin domain containing 9A (Clec9a) Antikörper
  • C-type lectin domain family 9, member A (CLEC9A) Antikörper
  • 9830005G06Rik Antikörper
  • DNGR-1 Antikörper
  • DNGR1 Antikörper
  • RGD1562513 Antikörper
  • UNQ9341 Antikörper

Bezeichner auf Proteinebene für CLEC9A

C-type lectin domain family 9 member A , dendritic cell natural killer lectin group receptor 1 , HEEE9341

GENE ID SPEZIES
232414 Mus musculus
283420 Homo sapiens
502901 Rattus norvegicus
100726117 Cavia porcellus
101119033 Ovis aries musimon
Ausgewählte Anbieter für CLEC9A (CLEC9A) ELISA Kits
Haben Sie etwas anderes gesucht?